You are here: Industry Insights > Sun Pharma

News List

Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis expresspharma
January 05, 2021
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon, informed the company.
Sun Pharma declares five-year positive results for ILUMYA (tildrakizumab-asmn) expresspharma
November 02, 2020
ILUMYA is approved for adults with moderate-to-severe plaque psoriasis and is being evaluated for other possible uses.
Sun Pharma, Strides Pharma recall drugs in the US expresspharma
October 12, 2020
Sun Pharma is recalling 747 bottles of generic diabetes drug due to higher levels of NDMA while Strides Pharma is recalling 11,280 bottles of potassium chloride extended-release tablets due to failed dissolution specifications.
Marksans Pharma and Sun Pharma voluntarily recall metformin expresspharma
October 10, 2020
FDA publishes a recalled metformin list including details about metformin products that have been recalled.
Sun Pharma recalls metformin due to high NDMA levels expresspharma
September 27, 2020
NDMA is classified as a probable human carcinogen based on results from laboratory tests.
Sun Pharma launches ILUMYA (tildrakizumab) in Japan expresspharma
September 23, 2020
It is indicated for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies.
Lupin, Sun Pharma recall drugs in US market expresspharma
August 10, 2020
Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg while Sun Pharma is recalling 3,516 bottles of Clonazepam orally disintegrating tablets.
Sun Pharma launches generic favipiravir, FluGuard at Rs 35 per tablet expresspharma
August 05, 2020
Sun Pharmaceutical Industries has launched FluGuard (Favipiravir 200 mg) at a price of Rs 35 per tablet, for the treatment of mild to moderate cases of COVID-19 in India.
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada) expresspharma
July 30, 2020
The cost of acquisition is about $8.2 million.
Pricing problems: Aurobindo Pharma, Sun Pharma, Lupin named in lawsuit in US expresspharma
June 16, 2020
Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the District of Connecticut, focuses on 80 topical generic drugs ...

Previous page 1 2 3 4 5 6 7 8 9 Next page